PMV Pharma

PMVP

1.2106.20% ( -0.080 )

Closed: Oct 16, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -1.21, within the reasonable range, cheaper than 32.67% of the time in the past 5 years, and the industry ranks 233/605, the industry Median -1.87.

-1.21xP/E

Stock price$1.21Earnings per share$-1.00

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

021426384

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GILDUSGilead Sciences	-59.77x	150.48%	$193.67B
MRNAUSModerna	-27.62x	15.45%	$87.04B
CSLLYUSCSL Limited	-24.77x	--	$63.89B
NTRAUSNatera	-294.84x	6.85%	$56.71B
RVMDUSRevolution Medicines	-21.57x	61.92%	$38.14B
ROIVUSRoivant Sciences	-90.96x	146.49%	$24.22B
BNTXUSBioNTech SE	-11.27x	19.07%	$22.03B
INSMUSInsmed	-24.02x	74.51%	$21.02B
BBIOUSBridgebio Pharma	-18.76x	28.67%	$12.98B
SMMTUSSummit Therapeutics	-13.63x	20.65%	$11.67B
MDGLUSMadrigal Pharma	-31.96x	51.32%	$10.39B
PCVXUSVaxcyte	-9.41x	48.18%	$10.01B
IBRXUSImmunityBio	-9.80x	151.32%	$9.73B
TWSTUSTwist Bioscience	-63.92x	28.71%	$8.74B
KYMRUSKymera Therapeutics	-29.08x	5.24%	$8.71B
CYTKUSCytokinetics	-9.63x	6.73%	$8.61B
ARWRUSArrowHead Pharma	-24.68x	35,923.70%	$7.90B
ABVXUSAbivax SA	-16.52x	22.49%	$7.68B
IONSUSIonis Pharma	-12.63x	50.43%	$7.14B
SYREUSSpyre Therapeutics	-46.90x	45.67%	$7.05B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.